HemeOxygenase-1 and Transplant Tolerance

HemeOxygenase-1 和移植耐受性

• 批准号: 8311915
• 负责人: LEO E OTTERBEIN
• 金额: $ 30.45万
• 依托单位: BETH ISRAEL DEACONESS MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-08-15 至 2013-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8311915
• 关键词: Accounting; Acute; Allograft Tolerance; Allografting; Antigens; Biliverdine; Bone Marrow; Breathing; Carbon Monoxide; Cell Maturation; Cell physiology; Cells; Chronic; Clinic; Clinical Protocols; Data; Dendritic Cells; Development; Disease; Generations; Genes; Goals; Health; Heart; Heme; IL2RA gene; ITGAX gene; In Vitro; Inbred BALB C Mice; Incidence; Knockout Mice; Lead; MAP Kinase Gene; MAPK14 gene; Maintenance; Mediating; Modeling; Mus; Organ; Organ failure; Outcome; PPAR gamma; Phase II Clinical Trials; Phenotype; Play; Population; Probability; Protocols documentation; Regimen; Regulatory T-Lymphocyte; Renal function; Role; Signal Pathway; Stimulus; T cell response; T-Lymphocyte; TNFSF5 gene; Testing; Transfusion; Transplant Recipients; Transplantation; base; beta catenin; end-stage organ failure; heart allograft; heme oxygenase-1; improved; in vivo; inhibitor/antagonist; meetings; mouse Cre recombinase; pre-clinical; prevent; research study; zinc protoporphyrin; zinc-protoporphyrin-9